Home

MICHAEL W ROGERS

CIK 1244159 · See Remarks · last filed 2026-06-22

MICHAEL W ROGERS is a corporate insider who has filed 56 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for AKBA, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$405.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $340.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$340.5K

Companies

10

Total Filings

56

Lifetime Open-Market Net

-$405.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AKBA Director 197,429 $0.87 $172.2K $0 9 2026-06-22
Aravive, Inc. (ARAV) Delisted Director — $0.04 — $0 3 2022-09-26
EYPT Director 11,917 $14.12 $168.3K $0 5 2019-06-27
Whitehawk Therapeutics, Inc. (ARPO) Delisted See Remarks — $33.00 — $0 2 2019-05-16
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 0 — — $0 4 2018-12-13
EyePoint, Inc. (PSDV) Delisted Director — — — $0 11 2017-12-19
Acorda Therapeutics, Inc. (ACOR) Delisted Chief Financial Officer 339 $0.66 $224 -$405.9K 10 2016-05-13
Fortress Biotech, Inc. (CNDO) Delisted Director — — — $0 2 2013-02-11
BG Medicine, Inc. (BGMD) Delisted EVP, CFO and Treasurer — — — $0 2 2012-02-24
IDEV Executive Vice President 0 $93.52 $0 $0 6 2009-02-25

Recent Filings

56 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 AKBA Grant (A) +35,700 $0 EDGAR
2025-06-11 AKBA Grant (A) +35,700 $0 EDGAR
2024-06-10 AKBA Grant (A) +30,000 $0 EDGAR
2023-06-08 AKBA Grant (A) +30,000 $0 EDGAR
2022-09-26 Aravive, Inc. (ARAV) Delisted Grant (A) — $0 EDGAR
2022-06-09 AKBA Grant (A) +13,700 $0 EDGAR
2021-09-13 Aravive, Inc. (ARAV) Delisted Grant (A) — $0 EDGAR
2021-06-03 AKBA Grant (A) +13,700 $0 EDGAR
2020-09-17 Aravive, Inc. (ARAV) Delisted Grant (A) — $0 EDGAR
2020-06-09 AKBA Grant (A) +13,700 $0 EDGAR
Showing 1–10 of 56
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.